Reliability and Validity of the Turkish Version of the Multiple Sclerosis Knowledge Questionnaire
NCT ID: NCT03927092
Last Updated: 2019-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
58 participants
OBSERVATIONAL
2016-05-31
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multiple Sclerosis Intimacy and Sexuality Questionnaire
NCT05374031
The Effect of Education Programme on School Age Children's Attitudes Towards Children With Special Needs
NCT06163521
Comparison of the Dual Task, Cognitive Skills and Physical Activity With Problematic Game Players and Control Subjects
NCT04860557
Motivational Interviewing in Adolescents With Epilepsy
NCT06412692
The Effect of Therapeutic Communication Program on the Psychological State of Children
NCT06275711
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multiple Sclerosis patients
Patients that attended an annual patient education seminar at the investigators' university hospital were asked to fill out the Turkish version of the Multiple Sclerosis Knowledge Questionnaire
Multiple Sclerosis Knowledge Questionnaire
A 25-item self-administered questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multiple Sclerosis Knowledge Questionnaire
A 25-item self-administered questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Attends the annual patient education seminar at the investigators' university hospital
* Older than 18 years of age
* Can read and write
Exclusion Criteria
* Unable to answer the questions due to a cognitive impairment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ege University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ece Cinar
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ece Cinar, M.D.
Role: PRINCIPAL_INVESTIGATOR
Ege University School of Medicine
Yesim Akkoc, M.D.
Role: STUDY_DIRECTOR
Ege University School of Medicine
Funda Calis, M.D.
Role: PRINCIPAL_INVESTIGATOR
Ege University School of Medicine
Musa Baklaci, M.D.
Role: PRINCIPAL_INVESTIGATOR
Ege University School of Medicine
Ozgul Ekmekci, M.D.
Role: PRINCIPAL_INVESTIGATOR
Ege University School of Medicine
Ayse N Yuceyar, M.D.
Role: PRINCIPAL_INVESTIGATOR
Ege University School of Medicine
References
Explore related publications, articles, or registry entries linked to this study.
Giordano A, Uccelli MM, Pucci E, Martinelli V, Borreani C, Lugaresi A, Trojano M, Granella F, Confalonieri P, Radice D, Solari A; SIMS-Trial group. The Multiple Sclerosis Knowledge Questionnaire: a self-administered instrument for recently diagnosed patients. Mult Scler. 2010 Jan;16(1):100-11. doi: 10.1177/1352458509352865. Epub 2009 Dec 7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-4.1/19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.